Tag: CymaBay Therapeutics

June 18, 2019

CymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar

CymaBay Therapeutics (NASDAQ:CBAY) has announced that the US Food and Drug Administration (FDA) has cleared the company’s investigational new drug...